{"name":"Jacobus Pharmaceutical","slug":"jacobus-pharmaceutical","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxOQVdXUm54OVFGbDNZcThiVE5FTDVxVkFmc08xeWlLZEk4VDZ4TVVIWERCYlJlVkJTbXE2YnhZY09zcVFsSGRxaVhZSFowazlCZGhjN1o1NVp1eDZ3ZWJDRVhMZVZZWm5kRzNmSlQwYkwyT2taTUlTRVBUZ24tUjd5RG9kbE95SEt4MVd1bnk1OW02RmtzdzJTV2ZVcDVLbm1TbE1fdlg4NzJfMm5sWEFUV21adVZpUkhablBWMlFrRlZqMnFXc2VPczkyUE9QSzNzQTBkVUFsN0RRTmV2Q1pZcHZaNHdaalJNMTMtelBWRDg0NW8?oc=5","date":"2026-03-09","type":"deal","source":"Pharmaceutical Executive","summary":"Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billion Definitive Agreement to Acquire Day One Pharmaceuticals - Pharmaceutical Exec","headline":"Mergers and Acquisitions Roundup: GSK and Alfasigma Enter Licensing Agreement for Linerixibat, Servier Enters $2.5 Billi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNSHdGUC1YNm9YZ2RNdFA0dmR0ZUxyN3JWbS0zSjQ0clV2bmJnVEtIOFRNeGRGSTNJTDF2YTlBQUZGODVwNUV1X1dfbUlveVM3WUhlamZmZGllRmJQajVhMUZLWkhmRmhJd3k5RGEtQUlQOW5PVVdtOUZpbktFRkFXdXJQZmQ3SXBHRTVicUp3?oc=5","date":"2025-01-17","type":"pipeline","source":"Pharma Voice","summary":"Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking - Pharma Voice","headline":"Musk’s rare disease torpedo, hospitals’ pharma fix and other policies leaders are tracking","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTFB5c3NWdWJ6aGVkTTVvNnBjdi1ETFhxTzFsUHJvV1FWbzlWb2RyeUNkT2F1Z0tNZUVGeUhLR096TmdaeFVwTFEtQmNoYjBMY0hLQy1Vd3VuUnNLWllzUUNBVHNnbEwtTEZaVjVjeEh0WVJkYjN6NHhxWA?oc=5","date":"2024-04-25","type":"trial","source":"Clinical Trials Arena","summary":"Ruzurgi (amifampridine) for the treatment of LEMS, US - Clinical Trials Arena","headline":"Ruzurgi (amifampridine) for the treatment of LEMS, US","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxNc0tiV2huWkk2QzViOU5xanlXcnptREZ5QWJadEdxVU5mSjlCZ0JkRElRNHZxaTJHcGhRbXVxc2JLTU1GNXo1c2FQUVYyVExzazBhSThYd0FDZE05Ul9aZXE0dFdaTTZ4cTR3TnNOTzE0U21Dam9OdUpmNGx5aGR3akc3QkR5S0JmV1l2MWRYTFZYdWxXdEloVU9pTFEwRkRRb0NWeG1NZ2laZmQ2QmxqY0hIYXpleGpzS3g5Sm1EQ1VzNHBReTZtUjM4dlROdDI0ZHRPVUF3RjM1T0pmc2R5OFpwM0E5VHc?oc=5","date":"2022-11-30","type":"regulatory","source":"Mayer Brown","summary":"Orphan Exclusivity in Catalyst’s Aftermath: FDA Inaction Leaves Rare Disease Sponsors in Limbo | Insights - Mayer Brown","headline":"Orphan Exclusivity in Catalyst’s Aftermath: FDA Inaction Leaves Rare Disease Sponsors in Limbo | Insights","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0gJBVV95cUxQU3NVSU9Ma3NQUHo1WEZZR3NoWmtWTlVfNVB5WkNNek1NR0VJNWJnWFltTFlyRXlDcmJfai13cnR5V1ljdDZzVXktNXRsWVpDVVltWVZSMXVyZ2F2LUFmbGNEUWpacjZkbVpkUjV4U1FIMVR5MWV2Ukw4UU5Ma2kzRUN3c0lCb1lRWkttTlBORllWOENORGlwR0M3enNNYnpqaFYwVk1Xdk1kMXRrSWRQSHNpMU9ib01pZ21xV0RiX21jV3Fwa09Ia3ZXWG1SaW5xRnpsQ3NoUmJoeTliLXdqb3Zoc1JWWERzbVFneU1zWTIzUHNYdzhvZm5kNUhjSm1zYW1RcVRZVkNIN09IZFYyanJrZDRwRWhBeVZhRkNkSzJfR0FNZFlya2cyZzBTa1Z2N3NnbHNSR0ZtcVVfbXRuVTU5aU5VckpIVUtCd1BBeW1YZw?oc=5","date":"2022-07-12","type":"pipeline","source":"GlobeNewswire","summary":"Catalyst Pharmaceuticals Announces Settlement of U.S. - GlobeNewswire","headline":"Catalyst Pharmaceuticals Announces Settlement of U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQdnpwQVN6Zy11TFZ2UjViUGlpZXg5dElxQzBDTHAxZFMwaGVWNy1uZDZuV1dKUGt4YnFscF9Eajc2QXRUVDl0TENIMjhldi1MQ2gxSXBvZVpMUjBGbm9Zc29qX0hXdnlZcjR1RGtMYTNEV2pLY2o3Z3NMa0lKWVo0SjVaMW1tQ3ZfTUF2aWl4ZFAtWnRLbUwwRVZCR2NVZ0k?oc=5","date":"2022-02-04","type":"regulatory","source":"Medical Professionals Reference","summary":"Ruzurgi Approval for LEMS No Longer Valid Following Court Decision - Medical Professionals Reference","headline":"Ruzurgi Approval for LEMS No Longer Valid Following Court Decision","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxPbmRDQXJxYVlINTNyOENKMFFoeEpfVTlJLTNKVzFtZDFhdk1CSm1rcnB5Tkl0WVZwWVBWMTVXQ2VQSE9ZcHNDWnZuVmc2NlZkclVMVnMwVXEwM0YtVmZobUN5Zi1GaEFodThlelpLVmxabXBGRTZtT1JDN0VLWGZnNTlDeEVkYUZZcmpDZGFrYklEWkpBM0VtVFNNMXR2akJ3R1REZWxvdllDVmZzQktwOWlCSENwc0lMbWNXQTloOTJqLWVtR21F?oc=5","date":"2021-10-01","type":"regulatory","source":"Fierce Pharma","summary":"U.S. appeals court sides with Catalyst, calling FDA approval of Jacobus' Ruzurgi 'arbitrary,' 'capricious' and unlawful - Fierce Pharma","headline":"U.S. appeals court sides with Catalyst, calling FDA approval of Jacobus' Ruzurgi 'arbitrary,' 'capricious' and unlawful","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiqwFBVV95cUxNWGlVbTV0eWYxTXVoWU10ay1XT0l2YXVFRzRSR01DaXBkekh5MU5FUkJfRGhwSzkySTViQ3A1RXI0dnU0T2JKbkxwZmloSy1ac280X01vcWV1UEpKaE4yYlZQRzhMdmVuXzRXSnhVYUtQbS01WFZDR2dNUy11bWNzVzYyWGtPXzBhMExLTnFCVDlXYkxhYkgwbmJzd044dGdGaU8ybTM3RXBpdEU?oc=5","date":"2019-06-12","type":"regulatory","source":"BioPharma Dive","summary":"Catalyst sues FDA, seeks to vacate approval of a competitor’s drug - BioPharma Dive","headline":"Catalyst sues FDA, seeks to vacate approval of a competitor’s drug","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNX0FRejNmY183X1pZZkZmZVc2c2RMc3ZDZDJlaXRrVGNGck1MM0VYUU1sYV83Yi0xeHlzc05nSDcwOWU2eXJmTlBGeUZPMWRUWGVkM0JORk9qaEdOS3EyMDNxV2lvZFR1aW9Xb3JtVnpNaHpYOXRKckIwem9OYmg3dGs1X1RVU2lKTjFjMkxHZVlsVWlaaHU0SGYxajRjV29qNTJIMA?oc=5","date":"2019-05-07","type":"regulatory","source":"pharmaphorum","summary":"Catalyst shares dive amid speculation about 'off-label' rare disease rival - pharmaphorum","headline":"Catalyst shares dive amid speculation about 'off-label' rare disease rival","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxNODlYaDZQVFNzcEdyeG1ZRWk4dWZQNm10dHZyY0lVVjAyNnRJVXFCS191RUhObUd0ZVZzUzctMVg3d3J5SURaQkdDc0VZcU9USDZtUzE3RWdtU1NBUTEyb0NsdDFSQmItOEU3eTF4ampYWHZ3T2VLOFZqWTB6dWcwdHlOYmg4MHN4bkJ4dGVn?oc=5","date":"2016-04-05","type":"pipeline","source":"statnews.com","summary":"A family-run drug maker faces tough choices to stay afloat in the Shkreli era - statnews.com","headline":"A family-run drug maker faces tough choices to stay afloat in the Shkreli era","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxQWTRiaE42VTBQNFFoVlMtaWxWdlZrZFBBdGI5S0dMNTB6VURYck94RG9uREZWaFBraWpjTGUybnM4OEZxMFNGY2kycTYwSldxR09naFAzLWt5cVp0MjNMcVlsbzJHakVLeVBiSnNDaHNPeV9GYThyX01jM3lRcHdBRWZudFpVNVI5bUEydi1ObDVTeFFIdmJIelZYUU5MbDlzNkp1LTFpZWxnYW42M0pqVHJzQTgzVVZ0WWZZRjNFazJwZzVUZVdReGFKTGc?oc=5","date":"2016-04-05","type":"pipeline","source":"BioSpace","summary":"Family-Run Drugmaker Jacobus Pharma Fights to Stay Alive in the Martin Shkreli Era of High Priced Drugs - BioSpace","headline":"Family-Run Drugmaker Jacobus Pharma Fights to Stay Alive in the Martin Shkreli Era of High Priced Drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNTVlUR3QtTFlxeFdSWGlwT0pLalpGN2FXcU1XU3JwZDdYUDBReDlFTzVUQ1V5YkV4VG9nYWhCRzZlaUVTSUt1ZC1LalVUZHkxeEpxYW11d3ZJcEl1QVkxVVVxOWtHdVZyRFN1dUtHWWVGaG1uMVBsamNndmVZQkJneXN4NWVzbzQzU05JMFFpcFo4QQ?oc=5","date":"2015-12-22","type":"pipeline","source":"The New York Times","summary":"Patients Fear Spike in Price of Old Drugs (Published 2015) - The New York Times","headline":"Patients Fear Spike in Price of Old Drugs (Published 2015)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}